Article content The family doctor of Italian tennis star Camila Giorgi claims the athlete asked him about getting a fake COVID-19 vaccination certificate. Article content Daniela Grillone told Italian publication Corriere del Veneto that neither Giorgi nor her family have actually received the COVID vaccine jab. Article content The doctor said 31-year-old Giorgi initially suffered from "so-called tennis elbow." Then last summer, she allegedly asked the doctor about getting false documentation for all mandatory vaccines, which included COVID. Article content "I can confirm with absolute certainty that none of the vaccines against the Giorgi family have actually been administered," Grillone said, per Yahoo! News Australia. Giorgi is in the midst of an investigation for allegedly receiving falsified vaccination proof documentation. The doctor herself isn't free of controversy, after being arrested last February for allegedly giving fake serum sho...
sfa stenosis :: Article Creator Spinal Stenosis: Causes And Symptoms Spinal stenosis is a condition in which open spaces within your spine get narrower. This puts pressure on your spinal cord and the nerves around it, which can cause pain and other problems. Your spinal cord is a key part of your central nervous system that connects your brain to your body. It rests in the spinal canal, which is formed by the hollow spaces in the center of each vertebra, the interconnected bones that make up your spine. The narrowing can happen in the spinal canal, in the spaces between your vertebrae, or at points where nerves from your spine branch out to other parts of your body. As these spaces get smaller, the tightness can pinch the spinal cord or the nerves around it, causing pain, tingling, or numbness in your legs, arms, or torso. Injuries and conditions such as arthritis can lead to spinal stenosis. It's most common in people over 50. There...
achondroplasia genetics :: Article Creator Vosoritide Beneficial For Children Younger Than 5 Years With Achondroplasia WEDNESDAY, Dec. 27, 2023 (HealthDay News) — For children with achondroplasia, vosoritide is associated with a gain in the change in height Z score from baseline and a mild adverse event profile, according to a study published in the January issue of The Lancet Child & Adolescent Health. Ravi Savarirayan, M.D., from the Royal Children's Hospital at the University of Melbourne in Australia, and colleagues conducted a double-blind, randomized phase 2 trial in 16 hospitals across Australia, Japan, the United Kingdom, and the United States to examine the safety and efficacy of vosoritide in children younger than 60 months with a clinical diagnosis of achondroplasia confirmed by genetic testing. Participants were enrolled into three cohorts based on age at screening: 24 to 59 months, 6 to 23 months, and 0 to 5 months (cohorts 1,...
Comments
Post a Comment